Tatva Chintan Pharma Chem vs Peers
- Market cap
- ₹4,194 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,290.82 – ₹2,420.28
Tatva Chintan Pharma Chem ranks 1st by market capitalisation among 1 Specialty Chemicals companies tracked by ATS. Its largest peers are Tatva Chintan Pharma Chem. Its P/E of 22.5 compares with a peer median of 22.5.
Tatva Chintan Pharma Chem vs Specialty Chemicals peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Tatva Chintan Pharma Chem | 1,792.80 | -3.38% | 4,194 | 22.5 | 2.85 | 14.5% | +18.5% |
| Tatva Chintan Pharma Chem | 1,792.80 | -3.38% | 4,194 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Tatva Chintan Pharma Chem peer comparison — frequently asked questions
Who are Tatva Chintan Pharma Chem's competitors?
Tatva Chintan Pharma Chem's listed peers in Specialty Chemicals include Tatva Chintan Pharma Chem, ranked here by market capitalisation.
How does Tatva Chintan Pharma Chem's P/E compare with its peers?
Tatva Chintan Pharma Chem trades at a P/E of 22.5, against a median of 22.5 across the 1 Specialty Chemicals peers shown.
Which is the largest company among Tatva Chintan Pharma Chem's peers?
By market capitalisation, the largest company in the group is Tatva Chintan Pharma Chem at ₹4,194 crore, against ₹4,194 crore for Tatva Chintan Pharma Chem.
Same Data For Peers
Trade Tatva Chintan Pharma Chem With ATS
Track TATVA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.